header logo

Daily Exchange Rates

Nov 19, 2026
Top News
NURA set to launch in early 2027
NURA set to launch in early 2027

A Japanese-inspired health screening experience focused on the early detection of several major lifestyle-related diseases and common cancers.

NURA, the international network of AI-powered preventive health screening centres operated by FUJIFILM DKH LLC, is set to expand to Sri Lanka through a strategic partnership with Innovative Health Solutions (Pvt) Ltd., a subsidiary of the Hayleys Group.

A health screening at NURA typically takes around 120 minutes, without the need for fasting or a doctor's prescription. Guests move through a carefully sequenced series of scans and tests covering major lifestyle-related diseases and common cancers, using advanced screening methods designed with comfort and safety in mind. 

The screening experience includes a one-on-one doctor consultation, with the health report provided on-site, allowing guests to complete the entire process in a single visit. The streamlined process is designed with guest comfort in mind, making comprehensive health screening convenient and easy to fit into a busy routine.

NURA's screening features Fujifilm's globally trusted Japanese imaging technology, including ultra-low-dose CT systems that use up to 97% less radiation than conventional CT scans. Drawing on decades of Fujifilm's imaging research, AI-assisted technologies enhance image quality and help doctors identify potential areas of concern, supporting clinical assessment and decision-making.

Commenting on NURA's expansion to Sri Lanka, Masaharu Morita, Founder and Director of NURA, said:

“In Japan, regular health screening is part of everyday life. People make it a habit long before they have any reason to worry. NURA brings that culture to the world. We already have centres in India, Mongolia, Vietnam, Thailand and Dubai, and we are proud to be coming to Sri Lanka next. NURA is a dedicated health screening centre where AI supports our doctors and ultra-low-radiation CT makes annual screening practical. Our goal is to make preventive care something everyone in Sri Lanka can approach with confidence and ease.” 

Those interested in learning more about NURA and receiving updates ahead of its opening are welcome to join the waitlist at www.nurahealth.lk/waitlist.

Masaharu Morita, Founder and Director of NURA.

MostRead
VideoStories
“A Share for Everyone”: 'Let's Know, Let's Learn, Let's Invest'

“A Share for Everyone”: 'Let's Know, Let's Learn, Let's Invest'

Sri Lanka shifts to growth phase with historic Rs. 2 trillion capital allocation

Sri Lanka shifts to growth phase with historic Rs. 2 trillion capital allocation

Sri Lanka Targets Above 5% Economic Growth through Priority Sector FDI

Sri Lanka Targets Above 5% Economic Growth through Priority Sector FDI

Private Sector Welcomes Continued Stability and Consistency in Budget 2027

Private Sector Welcomes Continued Stability and Consistency in Budget 2027

"No Excuse" for Market Manipulation:SEC Chief Highlights 'Naughty Boys' and Ethics at Investor Forum

"No Excuse" for Market Manipulation:SEC Chief Highlights 'Naughty Boys' and Ethics at Investor Forum

Exclusive interview | Mankiran Chowhan, Managing Director for India and Sri Lanka at Salesforce

Exclusive interview | Mankiran Chowhan, Managing Director for India and Sri Lanka at Salesforce

 IMF says fiscal support must protect vulnerable while safeguarding fiscal buffers

IMF says fiscal support must protect vulnerable while safeguarding fiscal buffers

Is Sri Lanka Transforming?| IMF Mission Chief Evan Papageorgiou | At HydePark

Is Sri Lanka Transforming?| IMF Mission Chief Evan Papageorgiou | At HydePark

Important message from the Central Bank Governor at the Planters’ Association of Ceylon’s AGM

Important message from the Central Bank Governor at the Planters’ Association of Ceylon’s AGM

“Is Sri Lanka’s USD 8 billion reserve target realistic?”

“Is Sri Lanka’s USD 8 billion reserve target realistic?”

Stock Market

Market Closed

Nov 12, 2026 - 10:43 PM

Share Volume

87,120,154

Turnover

2,975,051,491.55

ASPI

22,157.40

124.470.56%
S&P SL20

6,365.57

16.570.26%